Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms.
about
Clinical use and applications of histone deacetylase inhibitors in multiple myelomaEvolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative NeoplasmsNew Therapeutic Approaches in Polycythemia VeraA 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic MyelofibrosisHistone deacetylases and cancer.Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progression.Emerging treatments for essential thrombocythemiaTargeting Histone Deacetylases in Diseases: Where Are We?Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies.Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.Novel and emerging therapies for the treatment of polycythemia veraEmerging targeted therapies in myelofibrosis.Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options.Ruxolitinib for the treatment of patients with polycythemia vera.Honokiol induces cell cycle arrest and apoptosis via inhibiting class I histone deacetylases in acute myeloid leukemia.Investigational histone deacetylase inhibitors (HDACi) in myeloproliferative neoplasms.Identifying targets for the restoration and reactivation of BRM.A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia.Disruption to schizophrenia-associated gene Fez1 in the hippocampus of HDAC11 knockout mice.Transcriptional profiling of whole blood identifies a unique 5-gene signature for myelofibrosis and imminent myelofibrosis transformation.HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance.Megakaryocyte lineage development is controlled by modulation of protein acetylation.Pharmacotherapy of Myelofibrosis.Erythropoiesis: insights into pathophysiology and treatments in 2017.Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy.
P2860
Q26745930-B3F6E1FB-E7CC-48FC-8B66-1EB9CF3A29F7Q26766319-854B8148-5EDA-4B7F-AF99-2EC70CE9AC5CQ26795677-41AEBFC6-5AF1-45B3-B2AD-8AE2483848ADQ28553797-B75B91A4-D5DD-47FF-90A1-1CEF7E452FD5Q34298745-B6968044-246F-4C1E-90B7-6053D7F6945AQ34514329-FAE2C58F-8559-47FD-A8F8-C37EDA78B67BQ35683853-B0C5A97F-40E6-4411-99CB-F241D9EF18A5Q35821728-A451FCB3-7051-4548-916F-AEC62E3E53C3Q36001930-F6AC2461-CA75-43BB-A1EA-C80751409862Q36214527-67787870-A051-44FF-9C34-D362B7E1FD76Q37069633-8A481D40-2074-4489-A7C6-1FDFB4D3244FQ38025160-39B19F0F-2B46-4C07-9F9A-9A5162E3D734Q38255717-5E030248-5234-42CD-B4E5-ACE1CC2FA4DCQ38484321-E9C39F39-C1DF-42DE-8EF1-A328E05EBE9DQ38960006-B3772C0B-644C-4F21-BE98-430D7C000F68Q38984578-E596D177-1B0C-4952-A82F-21C6EA7A575AQ39176522-FF41922C-DE09-4A99-8A3C-29408556DF82Q39403830-120E3263-CB39-4994-9680-CE43B043D5B0Q41703572-F6CBE71E-36EA-438B-95F8-CBDF869F7F41Q41809175-D40D8BCE-ACA6-459E-9D9A-6E47C78C2146Q42426152-CDD4A2B8-F3CA-45B7-85F4-574BBE196091Q52716487-0C97365F-1F2F-4495-A928-A41A6773390DQ53119304-EE2ED7D4-CBD9-4343-A0EB-8EBFC2038DC2Q55436035-22BADA94-1812-4CF0-95AE-ECE83507BF77Q55485574-ADA2CB27-CF5E-4B4C-9BF1-952DDFCE22C7
P2860
Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Increased gene expression of h ...... myeloproliferative neoplasms.
@en
Increased gene expression of h ...... myeloproliferative neoplasms.
@nl
type
label
Increased gene expression of h ...... myeloproliferative neoplasms.
@en
Increased gene expression of h ...... myeloproliferative neoplasms.
@nl
prefLabel
Increased gene expression of h ...... myeloproliferative neoplasms.
@en
Increased gene expression of h ...... myeloproliferative neoplasms.
@nl
P2093
P2860
P1433
P1476
Increased gene expression of h ...... myeloproliferative neoplasms.
@en
P2093
Caroline Hasselbalch Riley
Hans Carl Hasselbalch
Mads Thomassen
Morten K Jensen
Thomas Stauffer Larsen
Torben A Kruse
P2860
P304
P356
10.3109/10428194.2011.597905
P577
2011-08-01T00:00:00Z